SYDNEY, Sept 17 Hong Kong-listed dietary supplements company Biostime International Holdings Ltd has agreed to buy Australian vitamin maker Swisse Wellness Pty Ltd for more than A$1.5 billion ($1.08 billion), Australian media reported on Thursday.
The company beat Shanghai Pharmaceuticals Holding and Chinese private equity firm Hony Capital in a sale managed by Goldman Sachs Group Inc, the Australian newspaper and Fairfax Media said in reports, citing unnamed sources.
00:02 AT&T Aims for an Empire in Merger Talks With Time Warner2
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T
12:55 McDonald's shares pop as investors cheer third-quarter beat
11:10 Merged BAT-Reynolds could be loaded with up to $55 billion of debt, analysts say